Financials in USD. Standardized financial statements.
A compact view of how SomnoMed Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $111.49M | $91.65M | $83.62M | $72.58M | $62.71M | $57.30M | $58.89M | $52.39M | $49.33M | $44.08M |
| Revenue Growth? | +21.6% | +9.6% | +15.2% | +15.7% | +9.4% | -2.7% | +12.4% | +6.2% | +11.9% | 0.0% |
| Cost of Revenue? | $44.76M | $36.52M | $37.85M | $33.43M | $28.80M | $27.28M | $24.32M | $20.54M | $20.52M | $18.74M |
| Gross Profit? | $66.73M | $55.13M | $45.77M | $39.15M | $33.90M | $30.01M | $34.57M | $31.86M | $28.81M | $25.34M |
| Gross Margin? | +59.9% | +60.2% | +54.7% | +53.9% | +54.1% | +52.4% | +58.7% | +60.8% | +58.4% | +57.5% |
| Operating Expenses? | $63.11M | $63.46M | $49.84M | $43.28M | $35.61M | $30.96M | $33.79M | $30.07M | $32.68M | $24.90M |
| Operating Income? | $3.62M | -$8.33M | -$4.07M | -$4.13M | -$651,380 | -$940,980 | $918,458 | $2.00M | -$3.73M | $117,558 |
| EBITDA? | $1.58M | -$2.33M | -$3.12M | -$1.98M | $628,177 | $4.31M | $3.12M | $3.67M | -$2.51M | $1.51M |
| Income Before Tax | -$763,863 | -$11.27M | -$7.05M | -$3.50M | -$733,899 | $746,993 | $607,233 | $1.84M | -$3.76M | $490,772 |
| Income Tax Expense | $2.69M | $971,100 | $821,637 | $930,607 | $349,162 | $1.19M | $646,619 | $1.61M | $399,335 | $423,587 |
| Net Income? | -$3.46M | -$12.24M | -$8.00M | -$4.44M | -$1.19M | -$1.12M | -$39,386 | $2.32M | -$3.34M | $165,005 |
| EPS? | $-0.02 | $-0.10 | $-0.10 | $-0.05 | $-0.01 | $-0.02 | $-0.23 | $0.04 | $-0.06 | $0.00 |
| Diluted EPS? | $-0.02 | $-0.10 | $-0.10 | $-0.05 | $-0.01 | $-0.02 | $-0.23 | $0.04 | $-0.06 | $0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality